webpackJsonp([0xd1876fd1feac],{194:function(e,t,a){"use strict";function l(e){return e&&e.__esModule?e:{default:e}}t.__esModule=!0;var n=a(1),i=l(n);t.default=function(){return i.default.createElement("div",null,i.default.createElement("div",{className:"breadcrumbs-title-container clear"},i.default.createElement("span",{className:"breadcrumbs bullet bullet-border-red bullet-outline"},"Health partners >Â "),i.default.createElement("h1",{className:"breadcrumbs-title"},"Cohorts")),i.default.createElement("article",{className:"two columns clear"},i.default.createElement("section",{className:"item wider"},i.default.createElement("h2",{className:"bullet bullet-bg-orange no-margin"},"CREACTIVE"),i.default.createElement("p",null,"Through the newly established CREACTIVE project, the PROSAFE consortium focuses attention on TBI, on which data collection started in March 2014. Traumatic brain injury (TBI) is among the leading causes of death and disability and the main cause of death among the under-45s."),i.default.createElement("p",null,"The aims of the project are to consolidate the existing network in order to better describe the epidemiology of moderate-severe TBI in 7 countries (Greece and Israel have now joined the consortium); build a prognostic model based on short- and long-term outcome measures; identify the most effective clinical interventions for optimally treating TBI patients, and recognize the determinants of optimal vs suboptimal performance.")),i.default.createElement("div",{className:"item narrower"},i.default.createElement("img",{src:"http://lorempixel.com/600/450/business/",className:"full-width",alt:"Placeholder"}))),i.default.createElement("article",{className:"two columns clear"},i.default.createElement("div",{className:"item narrower"},i.default.createElement("img",{src:"http://lorempixel.com/600/450/business/",className:"full-width",alt:"Placeholder"})),i.default.createElement("section",{className:"item wider"},i.default.createElement("h2",{className:"bullet bullet-bg-orange no-margin"},"EHDN"),i.default.createElement("div",{className:"subtitle"},"European Huntington's Ddisease Network"),i.default.createElement("p",null,"The EHDN is a nonprofit research network committed to advancing research, facilitating the conduct of clinical trials, and improving clinical care in HD. Through the EHDN a platform has been created such that basic scientists, clinicians, patients and families can collaborate on academic and industry studies to fulfil its mission. The EHDN is supported by and collaborates closely with CHDI Foundation, Inc."))),i.default.createElement("article",{className:"two columns clear"},i.default.createElement("section",{className:"item wider"},i.default.createElement("h2",{className:"bullet bullet-bg-orange no-margin"},"IMI"),i.default.createElement("div",{className:"subtitle"},"Innovative Medicine Initiative"),i.default.createElement("p",null,"The Innovative Medicines Initiative (IMI) is Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients."),i.default.createElement("p",null,"IMI supports collaborative research projects and builds networks of industrial and academic experts in order to boost pharmaceutical innovation in Europe.")),i.default.createElement("div",{className:"item narrower"},i.default.createElement("img",{src:"http://lorempixel.com/600/450/business/",className:"full-width",alt:"Placeholder"}))))},e.exports=t.default}});
//# sourceMappingURL=component---src-pages-health-partners-cohorts-js-f525af0828405fd020ca.js.map